Abbott Halts Use of HeartMate PHP Blood Pump After Death, Malfunctions

This article was originally published here

Abbott Laboratories, which acquired Minnesota medical device maker St. Jude Medical last month, is halting use of a commercially promising blood pump in the U.S. and Europe following a patient death and several malfunctions.

The device at issue, the HeartMate PHP catheter, consists of a propeller inside a thin wire cage that is inserted in the heart to keep blood flowing at a predictable rate during a procedure to unblock clogged blood vessels.

Touted as a key growth driver by St. Jude and most recently by Abbott, the device is approved for commercial sales in Europe, and was in advanced clinical testing in the U.S., including at two hospitals in Minnesota.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply